Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
about
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Imatinib Mesylate (Gleevec) an ...... and Neck Squamous Cell Cancer
@en
type
label
Imatinib Mesylate (Gleevec) an ...... and Neck Squamous Cell Cancer
@en
prefLabel
Imatinib Mesylate (Gleevec) an ...... and Neck Squamous Cell Cancer
@en
P1476
Phase II Study of Imatinib Mes ...... and Neck Squamous Cell Cancer
@en
P3098
NCT00485485
P580
2007-01-01T00:00:00Z
P582
2010-03-01T00:00:00Z